QQQ   377.93 (+1.02%)
AAPL   148.64 (-0.03%)
MSFT   308.13 (-0.33%)
FB   328.69 (+1.26%)
GOOGL   2,748.94 (-0.09%)
TSLA   1,024.86 (+12.66%)
AMZN   3,320.37 (-0.46%)
NVDA   231.66 (+1.94%)
BABA   176.17 (-0.86%)
NIO   41.27 (+6.15%)
CGC   13.57 (+1.42%)
GE   105.43 (+1.33%)
AMD   122.36 (+2.12%)
MU   68.76 (+1.85%)
T   25.64 (+0.59%)
F   16.00 (-1.72%)
ACB   7.18 (+1.56%)
DIS   172.01 (+1.53%)
PFE   43.15 (-0.02%)
BA   212.87 (-0.05%)
AMC   36.83 (+0.63%)
QQQ   377.93 (+1.02%)
AAPL   148.64 (-0.03%)
MSFT   308.13 (-0.33%)
FB   328.69 (+1.26%)
GOOGL   2,748.94 (-0.09%)
TSLA   1,024.86 (+12.66%)
AMZN   3,320.37 (-0.46%)
NVDA   231.66 (+1.94%)
BABA   176.17 (-0.86%)
NIO   41.27 (+6.15%)
CGC   13.57 (+1.42%)
GE   105.43 (+1.33%)
AMD   122.36 (+2.12%)
MU   68.76 (+1.85%)
T   25.64 (+0.59%)
F   16.00 (-1.72%)
ACB   7.18 (+1.56%)
DIS   172.01 (+1.53%)
PFE   43.15 (-0.02%)
BA   212.87 (-0.05%)
AMC   36.83 (+0.63%)
QQQ   377.93 (+1.02%)
AAPL   148.64 (-0.03%)
MSFT   308.13 (-0.33%)
FB   328.69 (+1.26%)
GOOGL   2,748.94 (-0.09%)
TSLA   1,024.86 (+12.66%)
AMZN   3,320.37 (-0.46%)
NVDA   231.66 (+1.94%)
BABA   176.17 (-0.86%)
NIO   41.27 (+6.15%)
CGC   13.57 (+1.42%)
GE   105.43 (+1.33%)
AMD   122.36 (+2.12%)
MU   68.76 (+1.85%)
T   25.64 (+0.59%)
F   16.00 (-1.72%)
ACB   7.18 (+1.56%)
DIS   172.01 (+1.53%)
PFE   43.15 (-0.02%)
BA   212.87 (-0.05%)
AMC   36.83 (+0.63%)
QQQ   377.93 (+1.02%)
AAPL   148.64 (-0.03%)
MSFT   308.13 (-0.33%)
FB   328.69 (+1.26%)
GOOGL   2,748.94 (-0.09%)
TSLA   1,024.86 (+12.66%)
AMZN   3,320.37 (-0.46%)
NVDA   231.66 (+1.94%)
BABA   176.17 (-0.86%)
NIO   41.27 (+6.15%)
CGC   13.57 (+1.42%)
GE   105.43 (+1.33%)
AMD   122.36 (+2.12%)
MU   68.76 (+1.85%)
T   25.64 (+0.59%)
F   16.00 (-1.72%)
ACB   7.18 (+1.56%)
DIS   172.01 (+1.53%)
PFE   43.15 (-0.02%)
BA   212.87 (-0.05%)
AMC   36.83 (+0.63%)
NASDAQ:PSTI

Pluristem Therapeutics Earnings Date, Estimates, & History

$2.85
+0.11 (+4.01 %)
(As of 10/25/2021 04:00 PM ET)
Add
Compare
Today's Range
$2.74
$2.93
50-Day Range
$2.46
$3.26
52-Week Range
$2.44
$11.85
Volume240,051 shs
Average Volume444,431 shs
Market Capitalization$91.21 million
P/E RatioN/A
Dividend YieldN/A
Beta2.31

Earnings Summary

Latest
Earnings Date
Sep. 12

Actual EPS
(Sep. 12)
-$0.46
Missed By -$0.06

Consensus EPS
(Sep. 12)
-$0.40

Skip Charts & View Estimated and Actual Earnings Data

Pluristem Therapeutics Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Pluristem Therapeutics Estimated Revenue and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Pluristem Therapeutics (NASDAQ:PSTI) Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20211($0.10)($0.10)($0.10)
Q2 20211($0.30)($0.30)($0.30)
Q3 20211($0.40)($0.40)($0.40)
Q4 20211($0.30)($0.30)($0.30)
FY 20214($1.10)($1.10)($1.10)

PSTI Earnings Information

Pluristem Therapeutics last announced its earnings results on September 12th, 2021. The biotechnology company reported ($0.46) EPS for the quarter, missing analysts' consensus estimates of ($0.40) by $0.06. Pluristem Therapeutics has generated $0.00 earnings per share over the last year. Earnings for Pluristem Therapeutics are expected to grow in the coming year, from ($1.52) to ($1.24) per share.

Pluristem Therapeutics (NASDAQ:PSTI) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueActions
9/12/2021Q4($0.4030)($0.46)($0.0570)
2/8/2021Q2 2021($0.27)($0.49)($0.22)($0.49)
5/6/2019Q3 2019($0.70)($0.90)($0.20)($0.09)
2/6/2019Q2 2019($0.90)($0.70)+$0.20($0.07)$0.05 million
11/8/2018Q1($0.90)($0.80)+$0.10($0.08)
9/27/2018Q4 2018($0.90)($0.90)($0.09)$0.05 million
5/10/2018Q3($0.90)($0.10)+$0.80($0.01)
2/6/2018Q2 2018($0.80)($0.80)($0.08)$0.05 million
11/14/2017Q1($0.80)($0.80)($0.08)
9/7/2017Q4 2017($0.70)($0.70)($0.07)
5/8/2017Q3 2017($0.70)($0.90)($0.20)($0.09)
2/8/2017Q2 2017($0.70)($0.80)($0.10)($0.08)
11/15/2016Q1 2017($0.80)($0.80)($0.08)
9/7/2016Q4 2016($0.80)($0.80)($0.08)
5/9/2016Q3 2016($1.00)($0.90)+$0.10($0.09)
2/8/2016Q2 2016($0.80)($0.50)+$0.30($0.05)$0.09 million$2.75 million
11/9/2015Q1 2016($1.10)($0.70)+$0.40($0.07)$0.09 million$0.10 million
9/10/2015Q4 2015($1.10)($0.70)+$0.40($0.07)$0.09 million$0.09 million
5/6/2015Q3 2015($1.80)($1.00)+$0.80($0.10)$0.19 million$0.10 million
2/5/2015Q2 2015($0.90)($0.90)($0.09)$0.10 million
11/6/2014Q1 2015($1.30)($0.90)+$0.40($0.09)$0.10 million$0.10 million
10/6/2014($1.30)($0.90)+$0.40
9/11/2014Q4 2014($1.30)($0.90)+$0.40($0.09)$0.10 million$0.09 million
5/8/2014Q3 2014($1.40)($1.40)($0.14)$0.20 million$0.10 million
2/5/2014Q2 2014($1.30)($1.10)+$0.20($0.11)$0.15 million$0.10 million
11/5/2013Q1 2014($1.30)($0.80)+$0.50($0.08)$0.15 million$0.10 million
9/11/2013Q4 2013($1.30)($1.20)+$0.10($0.12)$0.10 million
5/8/2013Q3 2013($0.90)($1.00)($0.10)($0.10)$0.20 million$0.19 million
1/31/2013Q2 2013($0.90)($0.80)+$0.10($0.08)
11/6/2012Q1 2013($0.80)($0.80)($0.08)
9/10/2012Q4 2012($0.90)($0.90)($0.09)
5/8/2012Q3 2012($0.90)($0.90)($0.09)
2/9/2012Q2 2012($0.50)($0.50)($0.05)
11/9/2011Q1 2012($0.60)($1.10)($0.50)($0.11)
9/12/2011Q4 2011($0.90)($0.90)($0.09)
5/11/2011Q3 2011($0.70)($0.70)($0.07)
(Earnings results data provided by Zacks Investment Research)












Pluristem Therapeutics (NASDAQ:PSTI) Earnings Frequently Asked Questions

When did Pluristem Therapeutics announce their last quarterly earnings?

Pluristem Therapeutics (NASDAQ:PSTI) last announced its quarterly earning data on Sunday, September 12, 2021. Learn more on PSTI's earnings history

Did Pluristem Therapeutics beat their earnings estimates last quarter?

In the previous quarter, Pluristem Therapeutics (NASDAQ:PSTI) missed the analysts' consensus estimate of ($0.40) by $0.06 with a reported earnings per share (EPS) of ($0.46). Learn more on PSTI's earnings details

How much revenue does Pluristem Therapeutics generate each year?

Pluristem Therapeutics (NASDAQ:PSTI) has a recorded annual revenue of $20,000.00.

How much profit does Pluristem Therapeutics generate each year?

Pluristem Therapeutics (NASDAQ:PSTI) has a recorded net income of -$29.15 million. PSTI has generated $0.00 earnings per share over the last four quarters.

What is Pluristem Therapeutics's EPS forecast for next year?

Pluristem Therapeutics's earnings are expected to grow from ($1.52) per share to ($1.24) per share in the next year.

This page was last updated on 10/25/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.